Zuoguang Wang

741 total citations
40 papers, 529 citations indexed

About

Zuoguang Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zuoguang Wang has authored 40 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Molecular Biology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zuoguang Wang's work include Hormonal Regulation and Hypertension (15 papers), Blood Pressure and Hypertension Studies (10 papers) and Mitochondrial Function and Pathology (6 papers). Zuoguang Wang is often cited by papers focused on Hormonal Regulation and Hypertension (15 papers), Blood Pressure and Hypertension Studies (10 papers) and Mitochondrial Function and Pathology (6 papers). Zuoguang Wang collaborates with scholars based in China, Italy and United States. Zuoguang Wang's co-authors include Ya Liu, Shaojun Wen, Jielin Liu, Xiao Li, Kuo Liu, Yuqing Lou, Chuang Li, Yongxin Jin, Jie Wen and Wei Gu and has published in prestigious journals such as PLoS ONE, Journal of Medical Virology and International Journal of Cardiology.

In The Last Decade

Zuoguang Wang

39 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuoguang Wang China 15 227 181 100 93 63 40 529
Yayoi Nishida Japan 16 190 0.8× 87 0.5× 84 0.8× 50 0.5× 34 0.5× 32 517
Chao‐Sheng Lo Canada 18 424 1.9× 196 1.1× 251 2.5× 70 0.8× 78 1.2× 34 875
Megan E. Rudock United States 9 174 0.8× 72 0.4× 131 1.3× 36 0.4× 94 1.5× 10 572
Brent W. Osborne United States 6 237 1.0× 167 0.9× 87 0.9× 26 0.3× 124 2.0× 7 523
Kazue Ishikawa Japan 11 127 0.6× 152 0.8× 153 1.5× 56 0.6× 46 0.7× 19 453
Shaonin Ji United States 12 294 1.3× 46 0.3× 129 1.3× 55 0.6× 122 1.9× 14 566
Changan Yu China 14 137 0.6× 118 0.7× 51 0.5× 41 0.4× 71 1.1× 32 487
Despina Tsorotes Australia 12 333 1.5× 249 1.4× 222 2.2× 49 0.5× 111 1.8× 12 890
Frank Fan Zhang United States 7 145 0.6× 82 0.5× 154 1.5× 41 0.4× 67 1.1× 7 414
Sybil Charrière France 13 129 0.6× 229 1.3× 167 1.7× 66 0.7× 66 1.0× 42 489

Countries citing papers authored by Zuoguang Wang

Since Specialization
Citations

This map shows the geographic impact of Zuoguang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoguang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoguang Wang more than expected).

Fields of papers citing papers by Zuoguang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuoguang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoguang Wang. The network helps show where Zuoguang Wang may publish in the future.

Co-authorship network of co-authors of Zuoguang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zuoguang Wang. A scholar is included among the top collaborators of Zuoguang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuoguang Wang. Zuoguang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Wei, Jielin Liu, Ya Liu, & Zuoguang Wang. (2025). Identification of potential biomarkers for hypertension based on transcriptomic analysis in rats. Hypertension Research. 48(6). 1939–1950.
2.
Liu, Kuo, Jielin Liu, Jielin Liu, et al.. (2023). Association study of WNK1 genetic variants and essential hypertension risk in the Northern Han Chinese in Beijing. Frontiers in Genetics. 14. 1234536–1234536. 1 indexed citations
3.
Wu, Hao, Jiang Xie, Yaxin Guo, & Zuoguang Wang. (2022). The independent role of nasal obstruction in resistant hypertension for uncontrolled hypertensive patients with obstructive sleep apnea. European Archives of Oto-Rhino-Laryngology. 280(4). 2017–2024. 1 indexed citations
4.
Wang, Zuoguang, Hao Wang, Qiong Wu, et al.. (2021). GATA2 promotes human vascular smooth muscle cell proliferation via mitofusin2-mediated Ras/Raf/MEK/ERK signaling pathway. International Journal of Cardiology. 346. 62–70. 6 indexed citations
5.
Zhou, Qi, Wenli Cheng, Zuoguang Wang, et al.. (2020). C1q/TNF‐related protein‐9 is elevated in hypertension and associated with the occurrence of hypertension‐related atherogenesis. Cell Biology International. 45(5). 989–1000. 1 indexed citations
6.
Sun, Dongdong, Chuang Li, Jielin Liu, et al.. (2019). Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene MFN2. DNA and Cell Biology. 38(8). 796–807. 45 indexed citations
7.
Li, Xiao, et al.. (2018). microRNA-21 and hypertension. Hypertension Research. 41(9). 649–661. 73 indexed citations
8.
Wang, Zuoguang, Ya Liu, Jielin Liu, et al.. (2018). Association of mitofusin 2 methylation and essential hypertension: a case-control study in a Chinese population. Hypertension Research. 41(8). 605–613. 14 indexed citations
9.
Liu, Jielin, Lei Xiao, Ya Liu, et al.. (2017). Recent development of risk-prediction models for incident hypertension: An updated systematic review. PLoS ONE. 12(10). e0187240–e0187240. 56 indexed citations
10.
Zhang, Bei, Mei Li, Jielin Liu, et al.. (2015). Comparing Direct Stenting With Conventional Stenting in Patients With Acute Coronary Syndromes. Angiology. 67(4). 317–325. 8 indexed citations
11.
Lou, Yuqing, Rong Li, Jielin Liu, et al.. (2015). Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma. Medical Oncology. 32(4). 132–132. 48 indexed citations
12.
Gu, Wei, Li Zhao, Zuoguang Wang, et al.. (2015). Association of the bradykinin receptors genes variants with hypertension: a case–control study and meta-analysis. Clinical and Experimental Hypertension. 38(1). 100–106. 3 indexed citations
13.
Liu, Jielin, Lijuan Wang, Ya Liu, et al.. (2014). The association between endothelial nitric oxide synthase gene G894T polymorphism and hypertension in Han Chinese: a case-control study and an updated meta-analysis. Annals of Human Biology. 42(2). 185–195. 18 indexed citations
14.
Wang, Lijuan, Bei Zhang, Mei Li, et al.. (2014). Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals. Hypertension Research. 37(12). 1068–1074. 17 indexed citations
15.
Wang, Hao, Jielin Liu, Kuo Liu, et al.. (2013). β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis. Molecular Biology Reports. 40(6). 4055–4063. 23 indexed citations
16.
Liu, Kuo, Jielin Liu, Yan Huang, et al.. (2010). Alpha-Adducin Gly460Trp Polymorphism and Hypertension Risk: A Meta-Analysis of 22 Studies Including 14303 Cases and 15961 Controls. PLoS ONE. 5(9). e13057–e13057. 19 indexed citations
17.
Wang, Zuoguang, Ya Liu, Jieling Liu, et al.. (2010). E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population. BMC Medical Genetics. 11(1). 127–127. 20 indexed citations
18.
Lou, Yuqing, Jinghua Liu, Yan Huang, et al.. (2010). A46G and C79G polymorphisms in the β2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis. Hypertension Research. 33(11). 1114–1123. 14 indexed citations
19.
Wang, Zuoguang, Xiaoyun Peng, Yanduo Tao, et al.. (2009). Is Prehypertension Really Different from Normotension and Hypertension? A Case-Control Pilot Proteomic Study in Chinese. Clinical and Experimental Hypertension. 31(4). 316–329. 6 indexed citations
20.
Liu, Yaping, Shaojun Wen, Yanhong Guo, et al.. (2007). [Hyperplasia suppressor gene expression in vascular smooth muscle cells derived from normotensive and hypertensive patients underwent bypass surgery].. PubMed. 35(10). 914–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yayoi Nishida Breakdown of academic impact, for papers by Chao‐Sheng Lo Breakdown of academic impact, for papers by Megan E. Rudock Breakdown of academic impact, for papers by Brent W. Osborne Breakdown of academic impact, for papers by Kazue Ishikawa Breakdown of academic impact, for papers by Shaonin Ji Breakdown of academic impact, for papers by Changan Yu Breakdown of academic impact, for papers by Despina Tsorotes Breakdown of academic impact, for papers by Frank Fan Zhang Breakdown of academic impact, for papers by Sybil Charrière
Rankless by CCL
2026